Dorota McKay - Jan 2, 2023 Form 4 Insider Report for VAPOTHERM INC (VAPO)

Role
Chief Accounting Officer
Signature
/s/Adrain Bryant, as Attorney In Fact
Stock symbol
VAPO
Transactions as of
Jan 2, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 05:10 PM
Previous filing
Nov 9, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VAPO Common Stock 31.9K Jan 2, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VAPO Stock Option (right to buy) Award $0 +18.2K $0.00 18.2K Jan 2, 2023 Common Stock 18.2K $2.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 5,000 shares that were purchased under the Vapotherm, Inc. 2018 Employee Stock Purchase Plan and 22,957 shares that will be issued over time upon vesting and settlement of restricted stock unit awards.
F2 This option was granted under the 2018 Equity Plan and will vest as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.